Drug Law Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Boston University, U.S.

Medical study results published by Boston University, U.S.

This trend article about Boston University, U.S. is an immediate alert from LawRx to identify developing directions of research.

Study 1: A lower 12 mcg/h dose of fentanyl transdermal delivery system (fentanyl TTS) provided a therapeutic benefit in nonmalignant chronic pain.

According to recent research from the United States, "The fentanyl TTS (Duragesic) is currently widely available in patch strengths of 25, 50, 75, and 100 mcg/h. However, a lower dose of 12 mcg/h would allow optimal titration and fine tuning of the analgesic effect, and may be beneficial in certain...

• View Other Issues of Drug Law Weekly
  
• View Other NewsRx Publications